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Keeping a lid on eosinophil activation
 
Spred-1 moderates eosinophil activation normally mediated by IL-5, according to a study by Inoue et al.
on page 73. Mice lacking Spred-1 have overly exuberant eosinophils and develop exaggerated allergic
responses to inhaled antigens.
Allergies and asthma are characterized by invasion of the airways by T cells and eosinophils. A subset
of CD4
 
 
 
 T cells, known as Th2 cells, produce an array of cytokines, including IL-5 and IL-13, which
recruit eosinophils to the lung where they release their stores of histamine and other
inflammatory proteins. The importance of Th2 cells and their associated cytokines
in allergic responses is well established, but less is known about the regulation of
eosinophil recruitment and activation.
The Spred (Sprouty-related EVH1 domain–containing protein) family of
membrane-bound proteins was identified recently by this group and shown to en-
code negative regulators of Ras–Erk signaling in neuronal cells. The demonstrated
importance of the Erk pathway in differentiation of Th2 cells and in eosinophil
survival prompted the authors to examine the role of Spred-1 in allergic asthma.
Mice lacking Spred-1 developed a more severe allergic reaction due to increased
numbers of eosinophils in the lungs. T cells, by contrast, were unaffected by the lack of
Spred-1—they were recruited in similar numbers and produced comparable amounts of
cytokines in its absence and its presence.
The authors attributed the exaggerated eosinophil recruitment to an increased sensi-
tivity to IL-5, since injection of IL-5, but not IL-13, into the lungs of Spred-1–deficient
mice caused increased recruitment of eosinophils. IL-5 stimulation of primary eosinophils
also resulted in hyperactivation of the Ras–Erk signaling pathway, but not of other
signaling pathways. Why a lack of Spred-1 had no effect on Th2 responses is not com-
pletely clear, but it may simply reflect the low expression levels of Spred-1 by T cells.
Allergic responses (purple) in the lung are 
increased in Spred-1-deficient mice (bottom).
 
Heart-stopping antibodies
 
Women with lupus and rheumatoid arthritis are at increased risk for having 
babies with congenital heart block, and maternal autoantibodies that cross 
the placenta are thought to be the main cause. On page 11, Salomonsson 
et al. show that a subset of autoantibodies that disrupt the calcium 
homeostasis in heart cells is responsible.
Women with autoantibodies specific for an intracellular protein of 
unknown function called SSA/Ro52 (Ro52) are more likely to have babies 
with congenital heart block—a condition in which the electrical impulses 
that regulate the heart beat are disrupted. The pathogenic response has 
been associated with the presence of antibodies that bind to one peptide 
on Ro52 called p200, but the mechanism was until recently a mystery. 
The authors have now pinpointed the pathogenic response even further 
by showing that not all p200-specific antibodies cause disease. They 
cloned two antibodies from rheumatic patients, which both recognized 
p200 but had distinct binding properties. One of these antibodies, but not 
the other, bound to neonatal rat heart cells and deregulated calcium 
homeostasis. Intracellular calcium accumulated in these cells, eventually 
triggering apoptosis. When sera from newborn children with congenital 
heart block were analyzed, there was a predominance of antibodies with 
binding properties similar to those of the pathogenic subset of p200-
specific maternal antibodies. 
The mechanism by which these antibodies interfere with normal 
calcium flux remains unsolved. The authors believe that in vivo the p200-
Autoantibodies cause calcium (blue) to accumulate in 
rat heart cells.
 
specific antibodies bind not to intracellular Ro52 but to a cross-reacting protein on the cell surface. They are 
now trying to identify that protein but meanwhile hope that this study will provide a new way to identify 
women who are most at risk for having children with congenital heart block.
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